Drug intelligence / Profile preview

myo-inositol + d-chiro-inositol + gymnema sylvestre + zinc + alpha-lactalbumin

Development stage
Unknown
Lead developer
Lo.Li. Pharma
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

This is a **combination dietary supplement** composed of five active ingredients: - **Myo-inositol** and **d-chiro-inositol** are stereoisomers involved in cell signaling and glucose metabolism, often used together in a 40:1 ratio to support insulin sensitivity and metabolic function, notably in polycystic ovary syndrome (PCOS) and type 2 diabetes[1][2][5][8][9]. These inositols act as insulin mimetics, improving ovarian function and metabolic profiles by modulating glucose uptake (myo-inositol) and glycogen synthesis (d-chiro-inositol)[5][9]. - **Gymnema sylvestre** is an herbal extract with traditional use in lowering blood glucose; it is thought to work by reducing intestinal glucose absorption and stimulating insulin secretion. - **Zinc** is an essential trace element involved in carbohydrate metabolism, insulin signaling, and antioxidant defense. - **Alpha-lactalbumin** is a whey-derived protein high in branched-chain amino acids and tryptophan, supporting muscle health and potentially enhancing mood via serotonin biosynthesis[3][6]. This combination is marketed as a supplement for improving insulin resistance, glycemic control, hormonal balance, reproductive health, and general metabolic wellness[1][2][4][5][7][9].

Brand names
Eudiamet 40:1
Other names
myo-inositol + D-chiro-inositol + gymnema sylvestre + alpha-lactalbumin + zinc
02

Targets

SLC39A6 (Solute carrier family 39 member 6)INSR (Insulin receptor)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)SLC5A1 (Sodium Glucose Cotransporter 1)

Beyond the preview

Go deeper on myo-inositol + d-chiro-inositol + gymnema sylvestre + zinc + alpha-lactalbumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on myo-inositol + d-chiro-inositol + gymnema sylvestre + zinc + alpha-lactalbumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call